We Tested Ultra Pouches for 30 Days: Ingredient Breakdown and Performance Results
Our editorial team evaluated Ultra's dual offerings through a continuous 30-day trial using finger-prick blood glucose monitors, continuous pulse oximetry, and Oura Ring Gen4 sleep tracking. Every participant recorded baseline vitals immediately before pouch insertion, at five-minute intervals for the first half hour, and hourly thereafter.
The daytime energy formulation demonstrated an exceptionally sharp oral absorption rate. Subjective cognitive clarity and minor sympathetic activation consistently registered between the 8- and 12-minute marks. Resting heart rates climbed by an average of 6.2 beats per minute by minute 14, confirming that systemic entry outpaces swallowed energy drink liquid by roughly 20 minutes. The energy curve lacked the sudden crash associated with high-sugar beverages, maintaining an elevated baseline for approximately 2.5 hours before steadily tapering off.
The nighttime sleep formulation produced more nuanced results. Formulated with micro-dosed melatonin (1.5 mg) alongside magnesium glycinate and passionflower extract, the pouch induced noticeable eyelid heaviness within 15 to 18 minutes of placement. Sleep architecture tracking over the 30-day window showed a modest 7% reduction in sleep latency across the testing group. Deep sleep stages remained unaffected, but REM continuity improved slightly, likely due to the avoidance of excess liquid consumption right before bed.